Summit Therapeutics plc
(‘Summit’ or the ‘Company’)Summit Therapeutics to Present at the 2019 BIO Investor ForumOxford, UK, and Cambridge, MA, US, 16 October 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM) announces that Mr Glyn Edwards, Chief Executive Officer, will present at the 2019 BIO Investor Forum on 22 October 2019 at 10:45am PDT in San Francisco.A live webcast of the presentation will be available in the Investors section of the Company’s website, www.summitplc.com. A replay of the webcast will be available from the same location soon after the live presentation.About Summit Therapeutics
Summit Therapeutics is a leader in antibiotic innovation. Our new mechanism antibiotics are designed to become the new standards of care for the benefit of patients and create value for payors and healthcare providers. We are currently developing new mechanism antibiotics for infections caused by C. difficile, N. gonorrhoeae and Enterobacteriaceae and are using our proprietary Discuva Platform to expand our pipeline. For more information, visit www.summitplc.com and follow us on Twitter @summitplc.Contacts-END-
Bay Street News